Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources Special Emphasis Panel, Clinical Research.
Date: August 29, 2002.
Time: 10 a.m. to Adjournment.
Agenda: To review and evaluate grant applications.
Place: Office of Review, National Center for Research Resources, 6705 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Sheryl K. Brining, Ph.D., Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, One Rockledge Centre, MSC 7965, 6705 Rockledge Drive, Suite 6018, Bethesda, MD 20892, 301-435-0809, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research 93.371, Biomedical Technology; 93.389, Research Infrastructure, National Institutes of Health, HHS)Start Signature
Dated: August 13, 2002.
LaVerne Y. Sringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-21343 Filed 8-21-02; 8:45 am]
BILLING CODE 4140-01-M